Sensitivity analysis of a parameterization of the stomatal component of the DO3SE model for Quercus ilex to estimate ozone fluxes.

R. Alonso,S. Elvira,M. Sanz,G. Gerosa,L. Emberson,V. Bermejo,B. Gimeno

DOI: https://doi.org/10.1016/j.envpol.2008.01.032

IF: 8.9

2008-10-01

Environmental Pollution

Abstract:

What problem does this paper attempt to address?

Amniotic membrane in the management of strabismus reoperations

Betul Tugcu,Firat Helvacioglu,Erdal Yuzbasioglu,Ceren Gurez,Ulviye Yigit

DOI: https://doi.org/10.1007/s10384-012-0217-5

Abstract:Purpose: To reduce postoperative scar formation and to improve duction using amniotic membrane (AM) in strabismus reoperations. Methods: A prospective study of interventional case series comprised of 14 patients with restrictive strabismus. Objective clinical findings (visual acuity, angle of deviations and degree of duction deficits) were recorded in both the pre- and post-operative periods. Strabismus surgery included the excision of adhesions and scar tissue, repositioning of extraocular muscles (according to the degree of deviations) and placement of two sheets, one between muscle and tenon and the other between muscle and sclera. Conjunctival recession with covering of the bare sclera using AM was also performed. Results: The mean preoperative deviation of the patients was 34.3 prism diopters (PD) and mean post-operative deviation was 4.6 PD. The mean pre-operative duction deficit of the patients was 1.7; mean post-operative duction deficit was 0.2. Postoperatively all patients improved in relation to deviation and duction. Less than 8 PD deviations with no duction deficits were achieved in 12 (86 %) of the patients. Conclusions: Amniotic membrane placement around the extraocular muscle improves the duction and decreases the residual angle of deviations by inhibiting postoperative scar formation.
The use of amniotic membrane for the management of fibrosis in complex strabismus surgery

Ourania Frangouli,Gillian G W Adams

DOI: https://doi.org/10.3109/09273972.2012.762531

Strabismus

Abstract:ABSTRACT Postoperative adhesion formation following complex strabismus surgery limits surgical outcomes. The benefits of amniotic membrane transplant (AMT) are widely recognized in ophthalmology. There are only published isolated case reports regarding its use in strabismus surgery. The limitation of these reports is that they describe use of AMT in cases of restrictive strabismus resulting from periocular surgery and indirect involvement of the extraocular muscles. In our series, the amniotic membrane was used to manage complex strabismus surgery. In this retrospective case series we describe surgical management with AMT in 8 strabismus cases between 2007 and 2010 in a tertiary referral center. Of these, 6 cases resulted from complex and repeat strabismus procedures to the extraocular muscles and 2 cases were a result of periocular surgery. Descriptive methodology was used. Outcomes examined were postoperative objective improvement in angle of deviation, subjective improvement in patient symptoms, and need for further interventions. Mean follow-up period was 15 months. All patients had multiple strabismus surgery in the past with a mean number of 3.2 ± 1.5 procedures (range 1-5). The indication for surgery using amniotic membrane graft was in 7 cases a large hypotropia with inferior conjunctival fibrosis and in one case a large consecutive horizontal deviation. The mean angle of vertical deviation was reduced from 32.1 ± 13 prism diopters (PD) preoperatively to 19.75 ± 11.4 PD postoperatively, with better outcomes in cases where AMT was used early in the surgical plan. Six out of the eight cases had objective improvement also consistent with improvement in the binocular field of vision. This is the largest reported case series on amniotic membrane grafts for strabismus surgery complicated by fibrosis and especially cases of consecutive hypotropia. Our outcomes indicate that AMT is beneficial, but we suggest it be used in the early stages of the surgical management of these cases.
Amniotic Membrane Transplantation in Strabismus Surgery

Rehab Rashad Kassem,Randa Mohamed Abdel-Moneim El-Mofty

DOI: https://doi.org/10.1080/02713683.2018.1562555

Abstract:Purpose: Adhesions between the extraocular muscles and surrounding tissues pose a main cause of failure of strabismus reoperations. Amniotic membrane (AM) transplantation during extraocular muscle surgery, to prevent the formation of adhesions, has been a subject of research during the past decade. This review aims to determine the value, indications, and tips on usage of AM transplantation during strabismus surgery. Materials and methods: All references cited in PubMed in English were searched using the key words: amniotic membrane strabismus or amniotic membrane extraocular muscles, and a brief summary of these was described. In addition, certain articles were chosen to provide introductory information on wound healing and fibrosis, AM properties and how it works after transplantation, and AM processing and preservation. Results: AM used for transplantation during extraocular muscle surgery may be cryopreserved, dried, or fresh. It may be oriented with its stroma or epithelium towards the muscle. It may or may not be fixed with sutures. What were the best choices? Various studies attempted to answer these questions. Many of the studies reviewed, however, were inconclusive or contradictory. Fresh AM seemed effective, but carried a risk of transmission of communicable diseases. Dried membrane was not of value in preventing adhesions. Histopathologically, cryopreserved membrane prevented the development of adhesions in the region of its presence, regardless of its orientation, and without the need for suture fixation. To accentuate this histopathological effect during clinical practice, it was recommended to utilize the largest segment possible of cryopreserved membrane and limit its usage to cases where adhesions are expected to be the main cause of failure of strabismus surgery. Conclusion: Cryopreserved AM transplantation was safe and histopathologically effective in preventing adhesions. This effect was, however, less pronounced clinically. Its use during strabismus reoperations is merited if previous recommendations and precautions are considered.
Amniotic Membrane Transplantation by Continuous Lock Stitch Suture for Diseases of Ocular Surface

ZHANG Zong-duan,JIN Xiu-ming,ZHAO Yun-e,QU Jia

DOI: https://doi.org/10.3760/cma.j.issn.1006-4443.2006.08.013

2006-01-01

Abstract:Objective To evaluate the efficacy of amniotic membrane transplantation with continu- ous lock stitch suture for diseases of ocular surface. Method Amniotic membrane transplantation with continu- ous lock stitch suture was performed in 31 eyes of 26 patients for diseases of ocular surface (group 1), Amniotic membrane transplantation with interrupted sutrue of simple continuous suture was performed in 34 eyes of 31 patients for diseases of ocular surface (group 2). Results In group 1,Amniotic membrane desquamated in 3 of 31 eyes within 3 weeks post-operatively, and persisted in 19 of 22 eyes after 3 weeks post-operatively, in 17 of 28 eyes corneal epithelialization within 2 weeks post-operatively. In group 2, Amniotic membrane desquamated in 15 of 34 eyes within 3 weeks post-operatively, and persisted in 6 of 21 eyes after 3 weeks post-operatively, in 12 of 32 eyes corneal epithelialization within 2 weeks post-operatively. Conclusions Amniotic membrane transplantation with continuous lock stitch suture can prevent amniotic membrane from desquamated and absorption, promote the epithelialization, reduce pain and increase the efficacy of amniotic membrane transplantation.
Processed amniotic membrane for conjunctival reconstruction in complex strabismus surgery

Sabine Naxer,Maren Horn,Michael Schittkowski

DOI: https://doi.org/10.1080/09273972.2018.1502794

2018-08-21

Strabismus

Abstract:Introduction: In ophthalmology amniotic membrane is usually used for the treatment of corneal ulcerations and chemical burns of the ocular surface. Also, it is useful in the treatment of conjunctival defects. There are few publications on the long-term outcomes with the use of amniotic membrane to replace the conjunctiva. In our cases, we used it in patients with restrictive strabismus or conjunctival problems during or following complex eye muscle surgery. Materials and methods: In this retrospective case study, we reviewed the charts of the patients who had been treated with Ambio5® (IOP Inc. USA) for the replacement of conjunctiva in the treatment of conjunctival problems during or following complex eye muscle surgeries in our ophthalmology department between 2009 and 2015. Ambio5® is a processed dry, multi-layered amniotic membrane of 110-micron thickness. Inclusion criteria were the use of it in the treatment of conjunctival problems during or following complex eye muscle surgery. Results: Thirty-two patients were identified. Among the 32 identified patients, 7 patients (6 female, 1 male) had restrictive conjunctiva following complex strabismus surgery with functional problems or aesthetic conjunctival scarring requiring transplantation. The mean age of these patients was 47 years (range: 22-60 years). Mean follow-up time was 32 months (range 18-55 months). Only one of these seven patients suffered a discomfort related to conjunctival scarring. The other six patients had restrictive strabismus, four of them suffered from Graves' ophthalmopathy. All patients improved although three patients developed symblepharon. One of these patients needed revision because of a symblepharon. Discussion: The result of our study indicates that commercially prepared amniotic membrane is a good alternative graft to replace conjunctiva. It helps to prevent or cure restrictive strabismus, scarring of the conjunctiva with discomfort, and lack of conjunctiva. It is possible that commercially storable products may increase the risk of symblepharon, the reason is unknown.
Amniotic membrane transplantation for the repair of severe conjunctival dehiscence after strabismus surgery with adjustable sutures

Mehmet Cem Mocan,Nathalie F Azar

DOI: https://doi.org/10.1016/j.ajo.2005.02.061

Abstract:Purpose: To evaluate the outcome of amniotic membrane transplantation (AMT) for the repair of severe conjunctival dehiscence that occurred during or after fornix-incision strabismus surgery with adjustable sutures. Design: Retrospective, interventional case series. Methods: Four patients in whom severe conjunctival dehiscence developed during or after strabismus surgery were treated with amniotic membrane grafts. The extent of conjunctival reepithelization over sclera, range of ocular motility, and patient comfort were evaluated immediately after the surgery and at 1, 2, and 4 weeks. Results: The mean follow-up period was 16 weeks (range 4 to 28 weeks). Conjunctival dehiscence was detected 0 to 14 days after surgery. AMT was performed 0 to 14 days later. The conjunctival defect was reepithelized in all patients by the fourth postoperative week without evidence of scarring or restriction of motility. Conclusions: In the treatment of large conjunctival defects that may follow strabismus surgery, AMT may be an alternative to conservative management or primary conjunctival closure.
Treatment and prevention of ocular motility restrictions with amniotic membrane transplantation

Héctor Fernández Jiménez-Ortiz,Raúl Sampedro Yañez,Beatriz Villarrubia Torcal,Borja Maroto Rodriguez,Sara Nava Pérez,Natalia Monja

DOI: https://doi.org/10.1080/09273972.2021.1987925

Strabismus

Abstract:We intend to investigate the indications, complications, and final results of amniotic membrane (AM) transplantation in ocular motility restrictions. Surgeons have tried to prevent restrictive adhesions between the extraocular muscles and surrounding tissues because they cause unpredictable results. AM transplantation wrapping extraocular musculature has been proposed as a technique with good results for this purpose. A search was carried out in Medline, Embase, Cochrane Library and Clinicaltrial, Lilac and Ibecs databases, using the indexed terms" amnion", "strabismus," "strabismus-subheading-surgery" and "ocular motility disorders." The only exclusion criteria were studies conducted in non-humans or studies with insufficient data on eye motility. No study was discarded for analysis because of language, age or methodology. This review includes 165 patients (223 eyes), with a mean follow-up of 11.49 months. The mean age was 21 years old, 47% were males and 57% were children. 14 studies conducted in humans were eligible: 4 single case, 8 case series, 1 cohort study and 1 randomized clinical trial. In the vast majority of these papers, use of AM transplantation to treat (12 out of 14 papers) or either to prevent (2 out of 14 papers) motility restrictions or restrictive strabismus secondary to muscular adhesions. All the studies except one presents very favorable results improving postsurgical eye motility. The cryopreservation method was more widely used, presenting a good safety profile with few adverse effects in the short and medium term. Significant improvement was reported in most patients after the use of amniotic membrane transplantation to treat or prevent ocular motility limitations. Very few complications or adverse effects were documented.
Amniotic membrane for reducing the formation of adhesions in strabismus surgery: experimental study in rabbits

David Kirsch,Marcia Serva Lowen,Mônica Fialho Fialho Cronemberger,Elcio Hideo Sato

DOI: https://doi.org/10.3928/01913913-20141021-06

Abstract:Purpose: To evaluate the effect of amniotic membrane in reducing inflammation, fibrosis, adhesion formation, and ocular motility restrictions following strabismus surgery. Methods: In the first stage of this prospective, randomized study, 17 rabbits underwent superior rectus muscle recession in both eyes. Surgery was performed in the same manner, but human amniotic membrane was placed over the muscle without sutures in the right eye after recession. After 15 days, the rabbits were killed and their orbits were exenterated and evaluated histopathologically to quantify tissue inflammation and fibrosis. In the second stage, 5 rabbits underwent the same procedure but were killed after 30 days. A dynamometer was used to measure the force required to displace all eyes. Results: At 15 days postoperatively, eyes with amniotic membrane exhibited an increased inflammatory response and less fibrosis than eyes without amniotic membrane. At 30 days postoperatively, eyes with amniotic membrane continued to exhibit increased inflammation and less fibrosis than eyes without amniotic membrane. In the dynamometer test, more force was needed to displace eyes without amniotic membrane after 15 days, but there was no significant difference between the forces required at 30 days. Conclusions: Human amniotic membrane in rabbits led to an increase in the inflammatory process and a decrease in fibrosis formation following strabismus surgery.
Amniotic membrane implantation to reduce extraocular muscle adhesions to a titanium implant

Reshma A Mehendale,Linda R Dagi

DOI: https://doi.org/10.1016/j.jaapos.2011.05.001

Abstract:Amniotic membrane grafts are used extensively for ocular surface reconstruction. We describe the case of a 66-year-old man with traumatic, restrictive strabismus. Amniotic membrane was applied to resolve symblepharon between the globe and lids and also to prevent re-formation of adhesions between extraocular muscles and adjacent titanium plates placed during prior surgery.
Multiple myeloma. A differential consideration for osteolysis surrounding total hip arthroplasties.

J. A. Shaw

DOI: https://doi.org/10.1016/S0883-5403(05)80191-3

1995-06-01

Abstract:
Changes in the Z disk of skeletal muscle induced by tenotomy

J. Resnick,K. Engel,P. G. Nelson

DOI: https://doi.org/10.1212/WNL.18.8.737

IF: 9.9

1968-08-01

Neurology

Abstract:
The use of amniotic membrane in reducing adhesions after strabismus surgery

Hosam Sheha,Victoria Casas,Yasutaka Hayashida

DOI: https://doi.org/10.1016/j.jaapos.2008.08.009

Abstract:Postoperative adhesions after strabismus surgery may influence surgical outcome. Different techniques have been used with varying success to reduce these adhesions. We describe a novel surgical technique in which amniotic membrane is used to wrap the extraocular muscles.
A controlled study of the role of cryopreserved amniotic membrane transplant during strabismus reoperations

Rehab Rashad Kassem,Ahmed Mostafa Kamal,Randa Mohamed Abdel-Moneim El-Mofty,Hala Mostafa Elhilali

DOI: https://doi.org/10.1016/j.jaapos.2017.03.002

Abstract:Purpose: To evaluate the effects of using cryopreserved human amniotic membrane (AM) transplant during strabismus reoperations. Methods: A total of 30 patients with persistent strabismus were included in this prospective study. Patients were divided into two groups of 15 patients each. The AM group underwent strabismus reoperation with wrapping of the muscles with cryopreserved amniotic membrane. Controls underwent strabismus reoperation without an AM wrap. Final follow-up visit was scheduled between 3 and 12 months postoperatively. Surgical success was defined as 0Δ-10Δ of horizontal tropia and 0Δ-4Δ of vertical tropia, with no limitation of ductions exceeding -1. A cosmetically acceptable outcome was defined as a tropia of 0Δ-15Δ. Results: Three patients were excluded in the AM group due to incomplete follow-up. A successful outcome was achieved in 7 patients in each group (58% and 47% in groups AM and C, resp.; P = 0.63). A cosmetically acceptable outcome was achieved in 10 patients in the AM group (83.3%) and 12 (80%) in the control group (P = 0.48). The mean ocular deviation angles improved to 8.7Δ ± 12Δ in the AM group and 12.3Δ ± 17.4Δ in the control group (P = 0.63). Ductions improved in 66.7% and 36.4% of the muscles with limited motility in groups AM and C, respectively (P = 0.019). Conclusions: Wrapping the extraocular muscles with cryopreserved AM during strabismus reoperations was of limited clinical benefit. We attributed this to the small segment of AM used and to the presence of other causes of failure rather than adhesions.
Non-pertussis components of combination vaccines: problems with potency testing.

D. Sesardic,C. S. Dawes,K. Mclellan,Z. Durrani,S. Yost,M. Corbel

DOI: https://doi.org/10.1006/BIOL.1999.0205

1999-06-01

Abstract:Vaccines comprising combinations of diphtheria, tetanus and pertussis (DTP) with Haemophilus influenzae type b polysaccharide-protein conjugate (Hib), inactivated poliomyelitis virus (IPV) and hepatitis B virus (HBV) are already available, and new combinations using acellular pertussis components in a triple vaccine (DTaP) are under development. Evidence to date has shown that control of the efficacy, safety and stability of combination vaccines cannot be based on information already available on the individual components or existing licensed formulations. Several examples of immunological interference between components of a combination vaccine have been observed both in clinical trials and in laboratory tests. Examples of these for D, T and Hib components in DTP and DTaP combinations have been investigated.
Sandwich (Amnion/Conjunctival-Limbal Autograft/Amnion) Transplantation for Recurrent Pterygium with Restrictive Strabismus

Hang Wong,Jia-Song Wang,Ya-Li Du,Hua-Tao Xie,Ming-Chang Zhang

DOI: https://doi.org/10.3390/jcm11237193

2022-12-03

Abstract:(1) Background: This study aimed to evaluate the clinical outcome of Sandwich (Amnion/Conjunctival-Limbal Autograft/Amnion) transplantation for recurrent pterygium with restrictive strabismus. (2) Methods: This retrospective study included 11 eyes in 11 patients diagnosed with recurrent pterygium with restrictive strabismus who received sandwich transplantation. The outcomes were measured by pterygium recurrence, best-corrected visual acuity, esotropia (prism diopters), and treatment complications. (3) Results: Eleven patients (six males, five females) had a mean age of 60.5 (range 36-80) years. The previously received pterygium excision surgery number was 1.8 ± 1.02 (range 1-4). The mean follow-up period was 19.9 ± 8.41 (range 12-36) months. All patients had a restriction of abduction in the previously operated eye, causing esotropia in the primary position. Pre-operative esotropia was 17.2 (range 10-30) prims diopter (PD). Five eyes (45.5%) had symblepharon before surgery. All patients were orthotropic until the last follow-up. Symblepharon was released in all eyes. Free ocular motility was present in all eyes. No donor site scar formation, scleral melt, or corneal ulcer was noted. (4) Conclusions: Sandwich transplantation for recurrent pterygium with restrictive strabismus is safe and effective.
Long-term follow-up of cryopreserved amniotic membrane transplant during strabismus reoperations: Up 85 months' follow-up

Rehab Rashad Kassem,Ahmed Mostafa Kamal,Randa Mohamed Abdel-Moneim El-Mofty,Hala Mostafa Elhilali

DOI: https://doi.org/10.1177/1120672118757432

Abstract:Purpose: To evaluate the long-term effect of cryopreserved human amniotic membrane transplant during strabismus reoperations. Methods: A total of 15 patients with persistent strabismus were included in a prospective study to evaluate the effect of wrapping the extra-ocular muscles with cryopreserved amniotic membrane during strabismus reoperations. The study end-point was the last follow-up visit. A successful outcome was defined as 0-10∆ of horizontal tropia and 0-4∆ of vertical tropia, with no limitation of ductions exceeding -1. A cosmetically acceptable outcome was defined as a tropia of 0-15∆. Results: Maximum follow-up was 85 months (mean: 25.4 ± 25.5 months). At the last follow-up visit, a successful outcome was achieved in 46.7%, a cosmetically acceptable outcome was achieved in 66.7%, and the mean ocular deviation angles improved from 38.60 ± 14.63∆, preoperatively, to 10.6 ± 11.08∆. Motility limitation on the final follow-up visit exceeded -1 in only 4/180 muscles (2.2%). Conclusion: The effect of cryopreserved amniotic membrane transplantation on the success of strabismus reoperations was moderate in terms of ocular alignment. Its effect was more pronounced in terms of ocular motility. The latter better reflects the level of adhesions. No long-term complications were documented, denoting safety of cryopreserved amniotic membrane usage during strabismus reoperations.
On Schematological Equivalence of Dataaow Networks

A. Rabinovich

Abstract:We consider the problem of determining when two dataaow networks with uninterpreted nodes always have the same input-output behavior. We deene a set of behavior-preserving transformations on networks and show that this set is \schematologically complete", i.e., networks have the same input-output behavior under all interpretations if and only if they can be transformed into isomorphic networks. As a by product, we obtain a polynomial algorithm for deciding schematological equivalence of dataaow networks.
Amniotic membrane transplants in the pediatric population

Mariam S Ahmad,Garett S Frank,Eric M Hink,Alan G Palestine,Darren G Gregory,Emily A McCourt

DOI: https://doi.org/10.1016/j.jaapos.2017.04.002

Abstract:Purpose: To investigate the indications for and results of amniotic membrane transplantation (AMT) for the treatment of ocular disease in pediatric patients at a single institution. Methods: The medical records of patients <18 years of age who underwent AMT for ocular disease between January 1, 2003, and September 1, 2015, were reviewed retrospectively. Patients were determined to have reached a clinical endpoint if there was resolution of the ocular condition being treated after AMT placement, no additional surgery required for treatment of the ocular condition, and no active disease at most recent follow-up. Results: A total of 48 records were reviewed. Of these, 32 patients (67%) received AMT for treatment of ocular disease related to Stevens Johnson syndrome (SJS), 29 (94%) of whom reached the clinical endpoint. The remaining 16 patients (33%) underwent AMT for indications other than SJS, including difficult-to-treat corneal epithelial defects and ulcers, conjunctival reconstruction, and scarring after strabismus surgery. Of these, 80% reached the clinical endpoint. There were no adverse effects related to AMT in either group. Conclusions: In our series, AMT was used successfully and without complications.
Effects of amniotic membrane on wound healing and adhesions in experimental strabismus surgery

Sibel Demirel,Huban Atilla,Aylin Okcu Heper,Necile Erkam

DOI: https://doi.org/10.1177/112067210901900601

Abstract:Purpose: To evaluate the efficiency of amniotic membrane in prevention of adhesion formation after strabismus surgery. Methods: A prospective, controlled study was conducted on 20 eyes of 10 pigmented rabbits. After disinsertion of the superior rectus muscle, under the muscle insertion area to induce adhesion formation, a partial-thickness 4 x 4 mm sclerectomy was performed in both eyes. In the right eyes, a piece of appropriate size human amniotic membrane was sutured on the sclerectomy site. As the control group, left eyes were operated with a similar procedure but without amniotic membrane transplantation. After 2 months, both eyes were enucleated to perform histopathologic examination. Results: There was no adhesion between the sclera and muscle in the amniotic membrane group; however, there were various degrees of adhesions in the control group (p=0.004). Fibrosis in rectus muscle was present in 40% of the specimens in the amniotic membrane group and 90% in the control group with a higher grade (p=0.023). The mean number of inflammatory cells was significantly higher in the amniotic membrane group (p=0.005). Conclusions: According to our results, amniotic membrane has antifibrotic effect but no anti-inflammatory effect in rabbit eyes due to possible xenograft reaction to human tissues. It is effective in prevention of adhesion formation with possible physical barrier action.
Amniotic membrane transplantation: structural and biological properties, tissue preparation, application and clinical indications

Francis W B Sanders,Jinhai Huang,Jorge L Alió Del Barrio,Samer Hamada,Colm McAlinden

DOI: https://doi.org/10.1038/s41433-023-02777-5

Abstract:The amniotic membrane is a single epithelial layer of the placenta. It has anti-inflammatory, anti-scarring, anti-angiogenic and possibly bactericidal properties. The basement membrane of the amniotic membrane acts as a substrate to encourage healing and re-epithelialisation. It has been used in many ocular surface diseases including persistent epithelial defects (corneal or conjunctival), chemical or thermal burns, limbal stem cell deficiency, cicatrising conjunctivitis, ocular graft versus host disease, microbial keratitis, corneal perforation, bullous keratopathy, dry eye disease, corneal haze following refractive surgery and cross-linking, band keratopathy, ocular surface neoplasia, pterygium surgery, and ligneous conjunctivitis. This review provides an up-to-date overview of amniotic membrane transplantation including the structural and biological properties, preparation and application, clinical indications, and commercially available products.

Sensitivity analysis of a parameterization of the stomatal component of the DO3SE model for Quercus ilex to estimate ozone fluxes.

Amniotic membrane in the management of strabismus reoperations

The use of amniotic membrane for the management of fibrosis in complex strabismus surgery

Amniotic Membrane Transplantation in Strabismus Surgery

Amniotic Membrane Transplantation by Continuous Lock Stitch Suture for Diseases of Ocular Surface

Processed amniotic membrane for conjunctival reconstruction in complex strabismus surgery

Amniotic membrane transplantation for the repair of severe conjunctival dehiscence after strabismus surgery with adjustable sutures

Treatment and prevention of ocular motility restrictions with amniotic membrane transplantation

Amniotic membrane for reducing the formation of adhesions in strabismus surgery: experimental study in rabbits

Amniotic membrane implantation to reduce extraocular muscle adhesions to a titanium implant

Multiple myeloma. A differential consideration for osteolysis surrounding total hip arthroplasties.

Changes in the Z disk of skeletal muscle induced by tenotomy

The use of amniotic membrane in reducing adhesions after strabismus surgery

A controlled study of the role of cryopreserved amniotic membrane transplant during strabismus reoperations

Non-pertussis components of combination vaccines: problems with potency testing.

Sandwich (Amnion/Conjunctival-Limbal Autograft/Amnion) Transplantation for Recurrent Pterygium with Restrictive Strabismus

Long-term follow-up of cryopreserved amniotic membrane transplant during strabismus reoperations: Up 85 months' follow-up

On Schematological Equivalence of Dataaow Networks

Amniotic membrane transplants in the pediatric population

Effects of amniotic membrane on wound healing and adhesions in experimental strabismus surgery

Amniotic membrane transplantation: structural and biological properties, tissue preparation, application and clinical indications